Radiostereometric Analysis of Fracture Healing in Distal Femur Fractures (RSA)

May 4, 2015 updated by: Mark Steven Vrahas, Massachusetts General Hospital
The investigators are doing this research study to look at how distal femoral fractures (knee bone break) heal. In this study, the investigators will use Radiostereometric Analysis (RSA) to look at how the pieces of femur bone move as the bone heals. RSA is a special x-ray that uses radiographs to measure very small movements in the bone over time. The question that will be answered by this study is whether RSA can be used as a tool to monitor fracture healing.

Study Overview

Status

Unknown

Intervention / Treatment

Detailed Description

Determining when a fracture has united can be very difficult. Plain radiographs are easy to obtain but are notoriously inaccurate for determining union. CT scans are more helpful, but are more costly and inconvenient. Artifacts from the metal implants often mask the visibility of the bone structure. In addition, the accuracy of CT scans for determining non-unions is not known. CT scanning will identify a nonunion when a clear persistent fracture line separates the fragments. Unfortunately, the scans often reveal some areas where bone has bridged the fracture, and other areas where the fracture line remains. Ultimately, no one knows the amount of bridging necessary to stop motion between the fragments. Often the best indication of fracture healing is the resolution of pain. However, patients' pain tolerance varies greatly. It is clear that our specialty needs better techniques to determine fracture union. This is particularly important since the market is introducing many new drugs that purport increased rate of fracture healing. If there are no standards to evaluate fracture healing, there is no way to determine drug efficacy.

Radiostereometric analysis (RSA) is a highly accurate, precise, safe and objective technique that uses radiographs to measure very small displacements and relative motion over time. It has been used successfully for some time to evaluate small changes in the position of prosthetic joints. There is some indication that this technique can also be used to evaluate healing by determining when motion between the fragments stops. A limited number of phantom model RSA in-vitro studies have proven useful for measuring the rigidity of different types of osteosyntheses methods. However, RSA has so far only been applied in a few in-vivo studies to evaluate fracture healing.

Osteosynthesis of distal femur fractures is challenging. Fractures are reduced through a large skin incision and often patients face non-union or union in a varus or valgus deformity after a long convalescence. That said, increased fracture fixation is now achievable through the newly invented locked angle screw plate system. The Synthes product, Less Invasive Stabilization System (LISS) plate is one example of this new system. The exact time of fracture healing, however, remains uncertain. No RSA in-vivo studies have been published among patients with distal femur fractures - but one RSA in-vitro study on 18 phantom distal femurs demonstrates RSA to be a relatively simple way to collect and analyze the relative motion between fragments fixed with the LISS.8 Given this, it should be possible to evaluate fragment motion in distal femur fractures stabilized using the LISS plate in order to evaluate healing.

At the time of surgery, sets of up to 9 RSA beads will be implanted on sides of the main fractures lines with the use of the inserter instrument and the image intensifier. In AO/OTA type 33A fractures, two sets will be implanted - one in the femoral shaft and one in the distal femoral epiphysis. In AO/OTA type 33C fractures with an extra fracture line through the epiphysis, three sets will be implanted - one in the femoral shaft, one in the main lateral condyle segment and one in the main medial condyle segment. No beads will be planted in comminuted bone fragments. Patients will be evaluated during outpatient follow-up visits standard for this fracture (2 weeks, 6 weeks, 3 months, 6 months and 1 year after surgery.)

The purpose of this study is to use RSA to evaluate fracture healing in distal femoral fractures osteosynthezed using the LISS.

Study Type

Observational

Enrollment (Anticipated)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02114
        • Recruiting
        • Massachusetts General Hospital
        • Contact:
        • Principal Investigator:
          • Mark S Vrahas, MD
        • Sub-Investigator:
          • Charles Bragdon, Ph.D
        • Sub-Investigator:
          • Jordan H Morgan, BS
        • Sub-Investigator:
          • Meridith Greene, BS
        • Sub-Investigator:
          • Audrey Nebergall, BS
      • Boston, Massachusetts, United States, 02115
        • Recruiting
        • Brigham & Women's Hospital
        • Principal Investigator:
          • Michael J Weaver, MD
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All potential subjects will be in the inpatient setting of Massachusetts General Hospital or Brigham & Women's Hospital at the time of recruitment awaiting surgery on their distal femur fracture

Description

Inclusion Criteria:

  • Male or female subjects aged 18 and older
  • Isolated distal femur fracture requiring surgical stabilization with a LISS plate
  • Subjects who are able to return to MGH for follow-up during the year following their injury.

Exclusion Criteria:

  • Subjects with expected limited life span less than a year.
  • Subjects who were non ambulatory prior to their injury
  • Female subjects who are pregnant
  • Subjects who are treated with an orthopaedic implant other than the LISS
  • Subjects with bone structure illnesses.
  • Pathologic fractures secondary to neoplasm
  • Subject with a severe open distal femur fracture with vascular damage
  • Subjects who are unable to attend post-operative outpatient appointments at the MGH

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Distal Femur Fracture, LISS Plate
Patients presenting with a distal femur fracture requiring surgical fixation with a Less Invasive Stabilization System (LISS) plate will have placement of RSA beads for analysis.
At the time of surgery sets of up to 9 RSA beads will be implanted on sides of the main fractures lines with the use of the inserter instrument and the image intensifier. In AO/OTA type 33A fractures two sets will be implanted - one in the femoral shaft and one in the distal femoral epiphysis. In AO/OTA type 33C fractures with an extra fracture line through the epiphysis, three sets will be implanted - one in the femoral shaft, one in the main lateral condyle segment and one in the main medial condyle segment. No beads will be planted in comminuted bone fragments. The fracture will then be plated with a LISS plate as it normally would.
Other Names:
  • RSA Biomedical Tantulum Markers
  • Synthes Less Invasive Stabilization System Fixation Plate

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in inter-fragmentary motion throughout the course of healing for distal femoral fractures.
Time Frame: Change in inter-fragmentary motion from baseline at 2 weeks, 6 weeks, 3 months, 6 months and 1 year postoperatively
Use radiostereometric analysis to measure inter-fragmentary motion
Change in inter-fragmentary motion from baseline at 2 weeks, 6 weeks, 3 months, 6 months and 1 year postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mark S Vrahas, MD, Massachusetts General Hospital
  • Principal Investigator: Charles Bragdon, Ph.D, Massachusetts General Hospital
  • Principal Investigator: Michael J Weaver, MD, Brigham and Women's Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2012

Primary Completion (Anticipated)

May 1, 2015

Study Completion (Anticipated)

June 1, 2015

Study Registration Dates

First Submitted

May 2, 2012

First Submitted That Met QC Criteria

May 4, 2012

First Posted (Estimate)

May 8, 2012

Study Record Updates

Last Update Posted (Estimate)

May 6, 2015

Last Update Submitted That Met QC Criteria

May 4, 2015

Last Verified

May 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • 2011P001012

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Distal Femur Fractures

Clinical Trials on Placement of RSA beads

3
Subscribe